Literature DB >> 10678640

Diagnostic utility of eosinophils in the pleural fluid.

M A Martínez-García1, E Cases-Viedma, P J Cordero-Rodríguez, M Hidalgo-Ramírez, M Perpiñá-Tordera, F Sanchis-Moret, J L Sanchis-Aldás.   

Abstract

This study was conducted to assess the prevalence of eosinophilia in 358 consecutive samples of pleural fluid (all cases corresponded to first thoracentesis), to review the cause of eosinophilic pleural effusions, and to determine whether the presence of eosinophils increases the likelihood of nonmalignant underlying disorders. Eosinophilic pleural effusions were identified in 45 patients (12.6%): malignant underlying conditions were diagnosed in 11 patients (24.4% with eosinophilic effusions) and benign aetiologies were found in 27 patients. Benign aetiologies included uncomplicated paraneumonic effusion in 10 patients, tuberculosis in seven, complicated paraneumonic in five, liver cirrhosis in three, hydronephrosis in one and pulmonary thromboembolism in one. Seven pleural effusions were idiopathic. There was no difference in the prevalence between eosinophilic and noneosinophilic effusions according to the different diagnoses. With parameters of sensitivity, specificity, pretest and post-test probability and positive and negative predictive values for any prevalence figure using the Bayes' theorem and for any value of eosinophils (both in percentage or absolute numbers) in the pleural fluid (receiver operating characteristic curve) an adequate predictor of benign disease was not found. It is concluded that pleural eosinophilia at the initial thoracentesis cannot be considered as a predictor of an underlying benign disorder.

Entities:  

Mesh:

Year:  2000        PMID: 10678640     DOI: 10.1183/09031936.00.15116600

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

1.  BTS guidelines for the investigation of a unilateral pleural effusion in adults.

Authors:  N A Maskell; R J A Butland
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.

Authors:  Georgios T Stathopoulos; Taylor P Sherrill; Sophia P Karabela; Kasia Goleniewska; Ioannis Kalomenidis; Charis Roussos; Barbara Fingleton; Fiona E Yull; R Stokes Peebles; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2010-07-01       Impact factor: 21.405

Review 3.  Management of malignant pleural effusion.

Authors:  Jack A Kastelik
Journal:  Lung       Date:  2013-01-13       Impact factor: 2.584

4.  Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-gamma via CXCR3 chemokines.

Authors:  Moe Akahira-Azuma; Marian Szczepanik; Ryohei F Tsuji; Regis A Campos; Atsuko Itakura; Narciss Mobini; Jennifer McNiff; Ivana Kawikova; Bao Lu; Craig Gerard; Jordan S Pober; Philip W Askenase
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

5.  Lactate determination in pleural and abdominal effusions: a quick diagnostic marker of exudate-a pilot study.

Authors:  Giovanni Porta; Fabio G Numis; Valerio Rosato; Antonio Pagano; Mario Masarone; Giorgio Bosso; Claudia Serra; Luca Rinaldi; Maria C Fascione; Annalisa Amelia; Fiorella Paladino; Fernando Schiraldi
Journal:  Intern Emerg Med       Date:  2017-09-30       Impact factor: 3.397

6.  Warfarin-induced eosinophilic pleural effusion.

Authors:  Yong-Min Jo; Tae-Ho Park; Il-Hwan Jeong; Hyun-Jeong Kim; Ji-Hye Ahn; Woo-Jae Kim; Young-Rak Cho; Hee-Kyung Baek; Moo-Hyun Kim; Young-Dae Kim
Journal:  Korean Circ J       Date:  2011-02-28       Impact factor: 3.243

Review 7.  Pleural effusion: diagnosis, treatment, and management.

Authors:  Vinaya S Karkhanis; Jyotsna M Joshi
Journal:  Open Access Emerg Med       Date:  2012-06-22

8.  Pirfenidone-induced Eosinophilic Pleurisy.

Authors:  Isano Hase; Bunpei Yamaguchi; Hidenori Takizawa; Hiroaki Arakawa; Hideo Sakuma; Koichi Fujiu; Hideaki Miyamoto; Yoshiki Ishii
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

9.  Diagnostic procedure for idiopathic eosinophilic pleural effusion: a single-center experience.

Authors:  Weizhan Luo; Yunxiang Zeng; Panxiao Shen; Jianxing He; Jinlin Wang
Journal:  BMC Pulm Med       Date:  2020-04-03       Impact factor: 3.317

10.  Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study.

Authors:  Minfang Li; Yunxiang Zeng; Sheng Chen; Jinlin Wang; Yaqing Li; Dan Jia
Journal:  BMC Pulm Med       Date:  2021-12-06       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.